Oct 11 (Reuters) – Shares of dialysis service providers fell sharply on Wednesday after Novo Nordisk’s (NOVOb.CO) Ozempic showed early signs of success in delaying the progression of kidney disease i… [+1962 chars]Read More
Ozempics early success in kidney disease trial drags on dialysis stocks Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/AHBNO2BUBNPCFNATO6JAAGGM5M.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4ZHOLSCHJVJLVOJJGVXWMQCR3U.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BGQ3NHPV2FIXLDX3RKZKIZCHGE.jpg)
